Saturday, November 26, 2022

Bariatric Endoscopy -What’s Latest?

Dear Dr. Renukaprasad A R,
In the field of bariatrics, endoscopy has myriad applications, including preoperative evaluation of the anatomy, preoperative planning, intraoperative management to address inadvertent technical errors, management of postoperative complications, and primary bariatric procedures, among others. With the advent of minimally invasive techniques, endoscopy has emerged as an attractive alternative for managing obesity.
To learn how endoscopy is applied in bariatrics, join expert Dr. Rakesh Kalapala in a Docplexus Surgery Suite session on the "Bariatric Endoscopy: Current Scenario," TODAY, 5:00 PM IST onwards.
Session Highlights -
  • Current primary therapies
  • Endoscopic management of complications
  • Bariatric endoscopy - An essential tool in the armamentarium of surgeons
Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Additional Doses of Measles and Rubella Vaccines for Children, & More

Docplexus is one of the world's largest online communities
Pune - 411045, India
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Friday, November 25, 2022

Benefits of Abemaciclib in HR+/HER2- Node-Positive EBC

Dear Dr. Renukaprasad A R,
Do you know how effective abemaciclib is for patients with hormone receptor-positive (HR+)/ human epidermal growth factor receptor-2 negative (HER2-) early breast cancer (EBC)?
Eli Lilly and Docplexus are hosting a Ramiven® EBC launch program and a panel discussion to address the clinical benefits of abemaciclib in both HR+/HER2- Node-Positive EBC and metastatic breast cancer with Dr. Shaheenah Dawood (UAE), Dr. Vamshi Krishna, Dr. Amit Rauthan, Dr. Vijay Agarwal, Dr. Bharat A. Vaswani, and Dr. Satheesh C. T.
Join us TODAY at 07:30 PM IST.

Looking forward to your active participation in this launch event.


Session Highlights -
  • Opening Remarks: Dr. Satheesh CT
  • Disease burden and unmet needs in HR+ HER2- EBC: Dr. Amit Rauthan
  • Current trials in the EBC setting & monarchE study: Dr. Shaheenah Dawood
  • Significance of abemaciclib in the MBC setting: Dr. Vijay Agarwal
  • Panel Discussion (moderated by Dr. Vamshi Krishna)
Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Nanoemulsions: Unique Solution to Dry Eyes

Dear Dr. Renukaprasad A R,
Tear film insufficiency is a significant factor in dry eye disease (DED). OTC eye lubricants are an old methodology to increase the tear film's lipid layer thickness (LLT). But they are unacceptable to many patients due to their viscous consistency and transient unpleasant effects such as blurring of vision and a reduction in contrast sensitivity. Nanoemulsions are unique eye drops that can successfully alleviate these issues and significantly increase the LLT.
Read this article for more information on how nanoemulsion eye drops can improve a patient's quality of life.
Highlights:
  • Restoring the LLT of the tear film is critical for dry eye relief
  • Conventional eye lubricants do have certain drawbacks
  • Nanoemulsions are more user-friendly than OTC eye drops
  • Nanoemulsions are more efficient in replenishing LLT
Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Thursday, November 24, 2022

Join Now I PCOS & Pregnancy: Complications and Management

Dear Dr. Renukaprasad A R,
Women with PCOS are three times more likely to have a miscarriage than those without it. They are also more likely to develop preeclampsia, gestational diabetes, and premature delivery. Therefore, identifying these risks during all three trimesters is important to ensure safe parturition.
Join the eminent experts, Dr. Madhuri Patil, Dr. Tejal Lathia, and Dr. S. Sampathkumari, in an exclusive DIWAS session moderated by Dr. Gagan Priya, where they will discuss "PCOS & Pregnancy - Case Discussion" on TODAY, 3:00 PM IST onwards.
Session highlights -
  • Case scenarios
  • Complications of PCOS
  • Management of PCOS in pregnancy
Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Wednesday, November 23, 2022

GLP-1 Agonists for DM Management: Evidence Analysis

Dear Dr. Renukaprasad A R,
GLP-1 receptor agonists have driven a major shift in managing diabetes mellitus(DM) owing to the many benefits they offer, including cardioprotection, renal protection, and good hyperglycemic control.
Join Dr. Supratik Bhattacharyya, an expert endocrinologist, in an exclusive MasterSeries session on "GLP-1 Agonists in DM management: Comparative Analysis" TODAY, 3:00 PM IST onwards.
Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*